Verrica Pharmaceuticals Inc. (VRCA)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Verrica Pharmaceuticals Inc. chart...

About the Company

We do not have any company description for Verrica Pharmaceuticals Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

31

Exchange

Nasdaq

$5M

Total Revenue

31

Employees

$288M

Market Capitalization

-4.91

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VRCA News

Verrica Pharmaceuticals Inc VRCA

4d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?

1d ago, source:

Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

Verrica Pharmaceuticals Secures Key FDA Designation for YCANTH, Enhancing Market Protection

26d ago, source: MyChesCo on MSN

WEST CHESTER, PA — In a significant development for Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), the company announced its ...

Verrica Pharmaceuticals to Spotlight Innovations at Needham Healthcare Conference

22d ago, source: MyChesCo on MSN

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced its participation in the 23rd Annual Needham Virtual ...

Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

24d ago, source: Yahoo Finance

WEST CHESTER, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases ...

Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA

1mon ago, source: Business Insider

March 26, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases ...

Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Announces that YCANTH Receives New Chemical Entity Status and Orange Book Listing from the FDA

1mon ago, source: Finanznachrichten

March 26, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring ...

Verrica Pharmaceuticals Inc VRCA

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Verrica Pharmaceuticals Inc (VRCA)

24d ago, source: Investing

Verrica Pharmaceuticals (NASDAQ:VRCA) Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...